Kabra Drugs Live Share Price Today, Share Analysis and Chart

Name: Kabra Drugs Ltd.: Is Infosys Ltd. worth buying?
Item: Kabra Drugs Ltd.
Rating: 2.490375
Author: Trendlyne DVM scores

Turnaround Potential

about

33.75 0.46 (1.38%)

130.2K

BSE Volume

BSE 13 Feb, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Medium Financial Strength

- / 100

Mid Valuation

- / 100

Technically Bullish

71.7 / 100

Kabra Drugs Live Price Chart

Loading Fundamental data..

Loading data..

5 Votes:

Buy 60.0%

Sell 20.0%

Hold 20.0%